H.I.G. Capital, a leading global alternative investment firm managing $74 billion in assets, has announced a strategic partnership with Barts Health NHS Trust to develop the first applied healthcare innovation building within the newly established Barts Life Sciences Cluster on Cavell Street in Whitechapel, London. The project brings together one of the largest NHS Trusts in the UK, a global investment firm, and a specialist science and technology developer to create new models of collaboration between clinicians, researchers, and industry partners. Spanning 170,000 square feet, the Cavell Street development is positioned as a landmark within the Cluster, signaling a new phase of health innovation in East London focused on merging clinical expertise with commercial capability.
Health Technology Insights: The Guthrie Clinic Announces New Chief Digital Officer
The Cavell Street facility will act as a hub for NHS-industry collaboration, allowing companies to work closely with Barts Health clinicians and researchers to develop, test, and refine next-generation technologies across MedTech, artificial intelligence, digital health, and other emerging life sciences fields. The project is designed to provide a cutting-edge environment where organisations can co-create and validate innovations directly in clinical settings, in partnership with staff from The Royal London Hospital and other Barts Health sites. By fostering collaboration in real care environments, the development aims to accelerate the pathway from prototype to patient while enhancing the UK’s capacity for NHS-integrated innovation.
Health Technology Insights: Rocket Doctor AI Partners to Boost AI Clinical Support in Alberta
Shane DeGaris, Group Chief Executive Officer of Barts Health NHS Trust, said that the Barts Life Sciences Cluster is designed to unite clinicians, patients, industry, and academic partners in new ways. He added that the Cavell Street project is the first concrete step toward realizing this vision by creating spaces where NHS teams can shape and test innovations directly in patient care settings, improving outcomes and supporting economic growth in East London. Jérôme Fouillé, Managing Director of H.I.G. Realty in Europe, said the partnership demonstrates H.I.G.’s commitment to fostering innovation-led developments. He noted that Cavell Street will provide a platform for global companies to collaborate with NHS clinicians and help establish the Cluster as a leading centre for applied healthcare innovation.
Health Technology Insights: Amphista Reveals AMX-883 Preclinical Data for AML Therapy
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
